Highbridge Capital Management’s Pfizer PFE Stock Holding History

Highbridge Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-22,661	Closed	-$784K	–	775
2018 Q2	$784K	Buy	+22,661	New	+$774K	0.02%	506
2018 Q1	–	Sell	-11,910	Closed	-$410K	–	1590
2017 Q4	$410K	Sell	11,910 -4,638	-28%	-$158K	0.01%	1035
2017 Q3	$560K	Sell	16,548 -514,141	-97%	-$16.5M	0.01%	858
2017 Q2	$16.9M	Buy	530,689 +460,176	+653%	+$14.5M	0.25%	99
2017 Q1	$2.29M	Buy	70,513 +22,767	+48%	+$718K	0.03%	427
2016 Q4	$1.47M	Sell	47,746 -8,221	-15%	-$251K	0.03%	449
2016 Q3	$1.8M	Sell	55,967 -104,768	-65%	-$3.5M	0.03%	450
2016 Q2	$5.37M	Buy	+160,735	New	+$5.13M	0.09%	250
2015 Q4	–	Sell	-9,802	Closed	-$293K	–	1726
2015 Q3	$293K	Sell	9,802 -147,349	-94%	-$4.72M	﹤0.01%	1240
2015 Q2	$5M	Sell	157,151 -92,436	-37%	-$3.01M	0.06%	310
2015 Q1	$8.24M	Buy	249,587 +231,142	+1,253%	+$7.35M	0.11%	228
2014 Q4	$545K	Sell	18,445 -88,009	-83%	-$2.52M	0.01%	800
2014 Q3	$2.99M	Sell	106,454 -3,057	-3%	-$85.8K	0.04%	389
2014 Q2	$3.08M	Sell	109,511 -18,655	-15%	-$532K	0.04%	327
2014 Q1	$3.9M	Buy	128,166 +23,715	+23%	+$707K	0.05%	294
2013 Q4	$3.03M	Buy	104,451 +65,664	+169%	+$1.91M	0.04%	332
2013 Q3	$1.06M	Buy	38,787 +4,427	+13%	+$120K	0.01%	656
2013 Q2	$913K	Buy	+34,360	New	+$949K	0.01%	697

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highbridge Capital Management's PFE Position: Q4 2018 in Review

Highbridge Capital Management sold out of Pfizer (PFE) in Q4 2018, closing a stake of 223,057 shares — an estimated $9.33M sold.

Highbridge Capital Management first reported a position in PFE in Q2 2013 and held it in 16 quarters. The position peaked at $58M in Q2 2014. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Highbridge Capital Management reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
Highbridge Capital Management sold 223,057 Pfizer shares in Q4 2018, an estimated $9.33M.
Highbridge Capital Management first reported a position in Pfizer in Q2 2013 and held it in 16 quarters.
Highbridge Capital Management's Pfizer position peaked at $58M in Q2 2014.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.